DSpace university logo mark
Advanced Search
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > University Hospital > Articles in academic journal >

Multicenter survey on hospital-acquired pneumonia and the clinical efficacy of first-line antibiotics in Japan.

File Description SizeFormat
IntMed47_245.pdf1.63 MBAdobe PDFView/Open

Title: Multicenter survey on hospital-acquired pneumonia and the clinical efficacy of first-line antibiotics in Japan.
Authors: Watanabe, Akira / Yanagihara, Katsunori / Kohno, Shigeru / Matsushima, Toshiharu / HAP study group
Issue Date: 15-Feb-2008
Publisher: Japanese Society of Internal Medicine / 日本内科学会
Citation: Internal medicine, 47(4), pp.245-254; 2008
Abstract: OBJECTIVE: The aim of this study was to investigate the pathophysiology of hospital-acquired pneumonia (HAP) and the clinical efficacy of its first-line treatment and to examine the validity of "the Japanese Respiratory Society (JRS) Guidelines for management of HAP". METHODOLOGY: The observational survey was conducted during the period of June 2002-May 2004 and patients with HAP were prospectively surveyed using the consecutive enrollment method. A total of 1,356 patients from 254 hospitals nationwide were analyzed. Clinical response to first-line antibiotics was evaluated at the end of the medication. RESULTS: The 30-day mortality rate was 19.8%. Patients were classified into four groups according to the JRS guideline criteria. There were remarkable variances in the number of cases of each group. Mild/moderate pneumonia with no risk factors (group I) accounted for 0.3% of all cases. The mortality rate tended to be higher, as clinical conditions became more serious (group II < III < IV). Alternatively, though categorized in the same group (group III), there was a difference in the mortality rate by the severity of pneumonia (severe cases 32.2% vs. moderate cases 11.0%). First-line medication using carbapenems accounted for 61.7% of total cases. The efficacy rate of guideline-concordant therapy was significantly higher than that of guideline-discordant therapy (54.2% vs. 41.7%). CONCLUSIONS: This is the first nationwide study on HAP in Japan. The clinical characteristics and prognosis of HAP were elucidated. Review of the current classification of the disease is required and these results provide valuable information for the next revision of the guidelines.
Keywords: Antibiotics / Guidelines / Hospital-acquired pneumonia / Surveillance
URI: http://hdl.handle.net/10069/22510
ISSN: 09182918
DOI: 10.2169/internalmedicine.47.0577
PubMed ID: 18277024
Rights: Copyright (c) 2008 by The Japanese Society of Internal Medicine
Type: Journal Article
Text Version: publisher
Appears in Collections:Articles in academic journal

Citable URI : http://hdl.handle.net/10069/22510

All items in NAOSITE are protected by copyright, with all rights reserved.


Valid XHTML 1.0! Copyright © 2006-2015 Nagasaki University Library - Feedback Powerd by DSpace